[Federal Register Volume 63, Number 24 (Thursday, February 5, 1998)]
[Notices]
[Pages 5958-5959]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-2786]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting of the National Cancer Institute Special Emphasis Panel (SEP) 
meeting:

    Name of SEP: In Vitro Screening and Evaluation of Chemicals and 
Preclinical Drugs for In Vivo Toxicology Selection.
    Date: February 17, 1998.
    Time: 9:00 a.m. to Adjournment.
    Place: Executive Plaza North, Conference Room H, 6130 Executive 
Boulevard, Bethesda, MD 20892.
    Contact Person: Courtney M. Kerwin, Ph.D., M.P.H., Scientific 
Review Administrator, National Cancer Institute, NIH, Executive 
Plaza North, Room 630I, 6130 Executive Boulevard, MSC 7405, 
Bethesda, MD 20892-7405, Telephone: 301/496-7421.

[[Page 5959]]

    Purpose/Agenda: To review, discuss and evaluate responses to a 
Request for Proposal.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Proposals 
and the discussions could reveal confidential trade secrets or 
commercial property such as patentable material and personal 
information concerning individuals associated with the proposals, 
the disclosure of which would constitute a clearly unwarranted 
invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: January 29, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-2786 Filed 2-4-98; 8:45 am]
BILLING CODE 4140-01-M